Professor Antonini’s research focuses on pharmacology of dopaminergic medications, neuroimaging as well as cognitive and behavioural aspects of Parkinson’s disease. In addition he is actively involved in the use of continuous infusion of levodopa and apomorphine as well as subthalamic nucleus deep brain stimulus (STN-DBS) for the treatment of motor fluctuations and dyskinesia of complicated Parkinson patients.
During his academic career he has published almost 200 peer-reviewed manuscripts and several book chapters. He has many society affiliations, including treasurer of the Association of Parkinsonism and Related Disorders.
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!